Saved in:
Bibliographic Details
Main Authors: Nayha Shetty, Rebecca L. Quiñonez, Marissa S. Ceresnie, Sunita Ghosh, Henry W. Lim, Tasneem F. Mohammad
Format: Artículo Open Access
Published: Wiley 2026
Subjects:
Online Access:https://onlinelibrary.wiley.com/doi/10.1111/php.70081
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867002786154020865
author Nayha Shetty
Rebecca L. Quiñonez
Marissa S. Ceresnie
Sunita Ghosh
Henry W. Lim
Tasneem F. Mohammad
author_facet Nayha Shetty
Rebecca L. Quiñonez
Marissa S. Ceresnie
Sunita Ghosh
Henry W. Lim
Tasneem F. Mohammad
Nayha Shetty
Rebecca L. Quiñonez
Marissa S. Ceresnie
Sunita Ghosh
Henry W. Lim
Tasneem F. Mohammad
collection Wiley Open Access
contents Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study Nayha Shetty Rebecca L. Quiñonez Marissa S. Ceresnie Sunita Ghosh Henry W. Lim Tasneem F. Mohammad Photochemistry and Photobiology Abstract Erythropoietic protoporphyria (EPP) and X‐linked protoporphyria (XLP) cause severe photosensitivity, resulting in significant quality of life (QoL) impairment. This study aims to evaluate the safety and efficacy of Polypodium leucotomos extract (PLE) as an adjunctive therapy in patients with persistent symptoms despite standard dosing of afamelanotide. In this prospective single‐center cohort study, eight adults with confirmed EPP or XLP and ongoing symptoms despite regular afamelanotide implants every 2 months were enrolled. Participants received 480 mg oral PLE daily for 4 months. QoL and symptom severity were measured using questionnaires at baseline, Day 60, and Day 120. Six participants completed the study. Statistically significant improvements in QoL were observed on Day 60 ( p  = 0.014), but not at Day 120 ( p  = 0.152). Half of participants reported reduced reaction severity. No adverse events occurred. Adjunctive PLE improved short‐term QoL in participants with incomplete symptom control on afamelanotide alone and was well tolerated. Larger studies are warranted. 10.1111/php.70081 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/php.70081
format Artículo Open Access
id wiley_oa_10_1111_php_70081
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study
Nayha Shetty
Rebecca L. Quiñonez
Marissa S. Ceresnie
Sunita Ghosh
Henry W. Lim
Tasneem F. Mohammad
Photochemistry and Photobiology
Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study Nayha Shetty Rebecca L. Quiñonez Marissa S. Ceresnie Sunita Ghosh Henry W. Lim Tasneem F. Mohammad Photochemistry and Photobiology Abstract Erythropoietic protoporphyria (EPP) and X‐linked protoporphyria (XLP) cause severe photosensitivity, resulting in significant quality of life (QoL) impairment. This study aims to evaluate the safety and efficacy of Polypodium leucotomos extract (PLE) as an adjunctive therapy in patients with persistent symptoms despite standard dosing of afamelanotide. In this prospective single‐center cohort study, eight adults with confirmed EPP or XLP and ongoing symptoms despite regular afamelanotide implants every 2 months were enrolled. Participants received 480 mg oral PLE daily for 4 months. QoL and symptom severity were measured using questionnaires at baseline, Day 60, and Day 120. Six participants completed the study. Statistically significant improvements in QoL were observed on Day 60 ( p  = 0.014), but not at Day 120 ( p  = 0.152). Half of participants reported reduced reaction severity. No adverse events occurred. Adjunctive PLE improved short‐term QoL in participants with incomplete symptom control on afamelanotide alone and was well tolerated. Larger studies are warranted. 10.1111/php.70081 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study
topic Photochemistry and Photobiology
url https://onlinelibrary.wiley.com/doi/10.1111/php.70081